Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
Globe Newswire•31/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.